C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/1992
12/23/1992	WO1992022570A1 Inhibitors of picornavirus proteases
12/23/1992	WO1992022569A1 Peptides with tachykinin antagonist activity
12/23/1992	WO1992022332A2 Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology
12/23/1992	WO1992022329A1 USE OF β-CELL TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF HYPERINSULINAEMIA AND ASSOCIATED DISEASES
12/23/1992	WO1992022328A1 USE OF β-CELL-TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF TYPE II DIABETES AND ASSOCIATED DISEASES
12/23/1992	WO1992022322A1 Lhrh analogs
12/23/1992	WO1992022317A1 Composition and treatment with biologically active peptides having c-terminal substitutions
12/23/1992	WO1992022315A1 Synthetic pulmonary surfactant peptides
12/23/1992	WO1992022308A1 Broad spectrum antimicrobial compounds and methods of use
12/23/1992	WO1992015605A3 Inhibitors of human neutrophil elastase and human cathepsin g
12/23/1992	EP0519554A1 Conjugates of the class II protein of the outer membrane of neisseria meningitidis and of HIV-1 related peptides
12/23/1992	EP0519469A1 Cloned glutamic acid decarboxylase
12/23/1992	EP0519013A1 Peptides stimulating cytotoxic t cells immune to hiv rt
12/23/1992	EP0518955A1 Chymotrypsin-like proteases and their inhibitors
12/23/1992	EP0518933A1 Leukaemia inhibitory factor
12/23/1992	EP0518908A1 Method for polymerization of epoxide compounds.
12/23/1992	CA2111672A1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis
12/23/1992	CA2111584A1 Use of b-cell tropin (acth 22-39) antagonists in the treatment of hyperinsulinaemia and associated diseases
12/23/1992	CA2111583A1 Use of b-cell-tropin (acth 22-39) antagonists in the treatment of type ii diabetes and associated diseases
12/23/1992	CA2111471A1 Inhibitors of picornavirus proteases
12/23/1992	CA2111342A1 Synthetic pulmonary surfactant peptides
12/23/1992	CA2111214A1 Composition and treatment with biologically active peptides having c-terminal substitutions
12/23/1992	CA2108263A1 M-protein peptides of influenza virus as antiviral agents
12/22/1992	US5173408 Mammalian pancreatic cholesterol esterase
12/21/1992	WO1993000361A1 Novel prolyl endopeptidase inhibitors sna-115 and sna-115t, production thereof, and strain which produces said inhibitors
12/21/1992	CA2089890A1 Prolyl endopeptidase inhibitors sna-115 and sna-115t, production thereof, and strain which produces said inhibitors
12/20/1992	CA2071088A1 Conjugates of the class ii protein of the outer membrane of neisseria meningitidis and of hiv-1 related peptides, and vaccines containing same
12/16/1992	EP0518656A2 Solid phase peptide synthesis
12/16/1992	EP0518655A2 Solid phase peptide synthesis
12/16/1992	EP0518557A2 Assay method for hydrolytic enzymes
12/16/1992	EP0517913A1 Inhibitions of endothelin formation
12/16/1992	EP0517817A1 Inhibitors of catalytic antibodies
12/16/1992	EP0517792A1 Terminally blocked antiviral peptides
12/15/1992	US5171839 Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom
12/15/1992	US5171838 Leu3a binding peptides
12/15/1992	US5171836 Bactericides for use aganist methicillin-resistant bacteria
12/15/1992	US5171835 LHRH antagonists
12/15/1992	CA1311583C Peptide derivatives and their application, in particular in therapy
12/14/1992	WO1992022571A1 Immunoassay for non-a non-b hepatitis
12/14/1992	CA2087974A1 Immunoassay for non-a non-b hepatitis
12/11/1992	CA2070719A1 Assay method for hydrolytic enzymes
12/10/1992	WO1992021698A1 DETECTION OF COLLAGEN DEGRADATION $i(IN VIVO)
12/10/1992	WO1992021367A1 T cell receptor peptides as therapeutics for immune-related disease
12/10/1992	WO1992017493A3 Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
12/10/1992	WO1992017025A3 GnRH analogs
12/10/1992	WO1992013878A3 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
12/10/1992	WO1992012996A3 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
12/10/1992	CA2110263A1 Detection of collagen degradation in vivo
12/09/1992	EP0517589A2 Tachykinin derivatives, their preparation and pharmaceutical compositions containing them
12/09/1992	EP0517464A1 Peptides useful in regulating the immune and nervous systems
12/09/1992	EP0516851A1 Physiologically active substance well capable of permeating biomembrane
12/09/1992	EP0516747A1 COMPOSITIONS AND METHODS FOR TREATING INFECTIONS CAUSED BY ORGANISMS SENSITIVE TO $g(b)-LACTAM ANTIBIOTICS
12/08/1992	US5169935 Solid phase synthesis
12/08/1992	US5169932 Hormone inhibitors, antitumor agents
12/08/1992	US5169862 Bactericides, viricides, antiprotozoa agents
12/08/1992	US5169773 Antibodies able to distinquish between cyclosporins and their metabolites; monotoring dosages; immunoassay; hybrid cells; kits
12/06/1992	WO1992021369A1 Synthetic calcitonin peptides
12/06/1992	CA2088922A1 Synthetic calcitonin peptides
12/05/1992	CA2070331A1 Tachykinin denved peptides and pseudopeptides, process for their preparation and pharmaceutical compositions containing them
12/04/1992	WO1992021366A1 Immunoregulatory and neuroregulatory pentapeptides
12/04/1992	CA2088664A1 Immunoregulatory and neuroregulatory pentapeptides
12/02/1992	EP0516070A1 Protected tryptophan derivatives, process to synthetize them and their use
12/02/1992	CN1019267B Synthetic vaccines for foot and mounth disease
12/01/1992	US5168045 Diagnostic systems and methods using polypeptide analogs of apolipoprotein e
12/01/1992	CA1311086C Chimeric peptides for neuropeptide delivery through the blood-brain barrier
11/1992
11/26/1992	WO1992021033A1 Determination of motifs of peptides on mhc molecules
11/26/1992	WO1992020801A1 Novel antipathogenic peptides and compositions containing same
11/26/1992	WO1992020798A1 HEREGULINS (HRGs), BINDING PROTEINS OF P185?erb2¿
11/26/1992	WO1992020711A2 Lhrh antagonists and intermediate products
11/26/1992	WO1992020710A1 Grf analogs xi
11/26/1992	WO1992020709A1 Galanin antagonist
11/26/1992	WO1992020707A1 Bombesin analogs
11/26/1992	WO1992020706A1 Endothelin antagonists
11/26/1992	WO1992020704A1 Peptidomimetic inhibitors of hiv gp120 binding to cd4
11/26/1992	WO1992020703A1 The use of nucleic acid analogues in diagnostics and analytical procedures
11/26/1992	WO1992020702A1 Peptide nucleic acids
11/26/1992	WO1992020363A1 Treatment of liver cancer
11/26/1992	WO1992020357A1 Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
11/26/1992	WO1992020356A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof
11/26/1992	WO1992018536A3 Method for detecting an localizing tissues having neurokinine 1 receptors
11/26/1992	DE4117507A1 Verfahren zur herstellung von n(pfeil hoch)6(pfeil hoch)-substituierten lysin-derivaten Process for the preparation of n (arrow up) 6 (arrow up) -substituted lysine derivatives
11/26/1992	CA2471093A1 Determination of motifs of peptides on mhc molecules
11/26/1992	CA2109805A1 The use of nucleic acid analogues in diagnostics and analytical procedures
11/26/1992	CA2109503A1 Galanin antagonist
11/26/1992	CA2109206A1 Treatment of liver cancer
11/26/1992	CA2108754A1 Endothelin antagonists
11/26/1992	CA2086676A1 Grf analogs xi
11/26/1992	CA2083272A1 Novel antipathogenic peptides and compositions containing same
11/25/1992	EP0515313A2 Somatostatin analogues containing chelating groups and their radiolabeled compositions
11/25/1992	EP0514721A1 Peptides having thrombospondin-like activity and their therapeutic use
11/25/1992	EP0514475A1 CYCLIC GnRH ANTAGONISTS
11/25/1992	EP0514464A1 Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell
11/25/1992	EP0514460A1 Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
11/25/1992	EP0514413A1 Immunologically active peptides or polypeptides from the parvovirus b19.
11/25/1992	EP0500685A4 Method to identify analyte-binding ligands
11/25/1992	EP0348399B1 Sorbin and peptide derivatives which increase aborption by the mucous membranes
11/25/1992	CA2331239A1 Structure, production and use of heregulin
11/24/1992	US5166394 Coupling reagent for peptide synthesis
11/24/1992	US5166136 Antagonist of P undecapeptides as antiinflammatory agents and analgesics and for skin disorders
11/24/1992	US5166135 Method for the control of pneumocystis carinii

1 ... 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 ... 423